Southern Hemisphere Flu Redacted JA 2026 2027 _Redacted.pdf

This document is a Justification for Other Than Full and Open Competition for the Southern Hemisphere Influenza Vaccine, issued by the Defense Logistics Agency (DLA) Troop Support, Medical Supply Chain. The procurement seeks a one-year firm fixed price indefinite quantity contract for Fluzone® Southern Hemisphere Influenza Vaccine, with Sanofi Pasteur Inc. as the sole source. The requirement is for a minimum of 4,500 packages (45,000 doses) and a maximum of 9,000 packages (90,000 doses), with the vaccine indicated for active immunization for persons six months of age and older. Market research confirmed Sanofi Pasteur as the only FDA-approved manufacturer of this specific vaccine in the US, with the influenza season running from April through October in the Southern Hemisphere. The contract will be synopsized on Sam.gov, and the government has produced a specification with essential characteristics to foster potential competition.